<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04461860</url>
  </required_header>
  <id_info>
    <org_study_id>SCVPC (29BRC20.0089)</org_study_id>
    <nct_id>NCT04461860</nct_id>
  </id_info>
  <brief_title>Assessment of Pain of Pelvic Congestion Syndrome Treated by Coils Embolization</brief_title>
  <acronym>SCVPC</acronym>
  <official_title>Assessment of Pain of Pelvic Congestion Syndrome Treated by Coils Embolization (SCVPC)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Summary:&#xD;
&#xD;
      Main Objective: to evaluate the efficacy of pelvic gonadal vein embolization with coils in&#xD;
      treatment of pelvic congestion syndrome Methods: retrospective study included 25 patients in&#xD;
      the University hospital of Brest.&#xD;
&#xD;
      The Primary Outcome Measure: To evaluate (to measure) pain relief using visual analogous&#xD;
      scale (VAS) before and after gonadal vein embolization for pelvic congestion syndrome The&#xD;
      Secondary Outcome Measures were to assess the impact of the treatment on specific and general&#xD;
      symptoms through a survey.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A retrospective, non-invasive monocentric study of our Hospital 10-year registry (including&#xD;
      data on MRI angiography and Vascular Doppler Ultrasound) of patients who have already&#xD;
      undergone coil embolization of pelvic gonadal vein in treatment of pelvic congestion&#xD;
      syndrome. These patients will be contacted by phone to participate in the study. An&#xD;
      information letter will be handed out and the study protocol will be explained to the&#xD;
      patients. After obtaining their written consent, they will be asked to fill out the study's&#xD;
      validated questionnaire at home and return it to us through pre-paid regular mail. A face to&#xD;
      face interview with the patient will be scheduled to assess the correlation between patient's&#xD;
      clinical symptoms and survey results. There will be no change in patient's routine follow-up&#xD;
      care.&#xD;
&#xD;
      All physician investigators of the study are experts in their field of medicine (e.g.&#xD;
      interventional MRI angiography, vascular disease).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 21, 2020</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pelvic congestion pain relief</measure>
    <time_frame>pre-embolization and 1 month post-gonadal vein embolization</time_frame>
    <description>To evaluate (to measure) pain relief using visual analogous scale before and after gonadal vein embolization for pelvic congestion syndrome. A high score means a worse outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>evaluation of specific pelvic syndrome symptoms using a self-reported questionnaire survey</measure>
    <time_frame>pre-embolization and 1 month post-gonadal vein embolization</time_frame>
    <description>to assess the impact of gonadal vein embolization on specific symptoms of pelvic congestion syndrome through a self-reported questionnaire survey.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>evaluation of general pelvic syndrome symptoms using a self-reported questionnaire survey</measure>
    <time_frame>pre-embolization and 1 month post-gonadal vein embolization</time_frame>
    <description>to assess the impact of gonadal vein embolization on general symptoms of pelvic congestion syndrome through a self-reported questionnaire survey.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Pelvic Pain</condition>
  <eligibility>
    <study_pop>
      <textblock>
        women &gt; 18 years old with at least 1 previous pregnancy and delivery&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical symptoms of pelvic congestion syndrome documented by Vascular Doppler&#xD;
             ultrasound and vascular dynamic MRI&#xD;
&#xD;
          -  Failed medical treatment.&#xD;
&#xD;
          -  &gt; 18 years &lt; 60 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  &lt; 18 years old&#xD;
&#xD;
          -  Under legal guardian&#xD;
&#xD;
          -  Asymptomatic pelvic congestion syndrome&#xD;
&#xD;
          -  Psychiatric disorder&#xD;
&#xD;
          -  Endometriosis.&#xD;
&#xD;
          -  Chronic pelvic disease&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Neoplasia&#xD;
&#xD;
          -  Acute intermittent porphyria&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Philippe QUEHE</last_name>
    <phone>02 98 34 75 45</phone>
    <email>philippe.quehe@chu-brest.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU de Brest</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe QUEHE</last_name>
      <email>philippe.quehe@chu-brest.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>June 19, 2020</study_first_submitted>
  <study_first_submitted_qc>July 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 8, 2020</study_first_posted>
  <last_update_submitted>July 7, 2020</last_update_submitted>
  <last_update_submitted_qc>July 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>syndrome</keyword>
  <keyword>pain</keyword>
  <keyword>pelvic</keyword>
  <keyword>vein</keyword>
  <keyword>embolization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pelvic Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Data will be available beginning one year and ending five years following the end of the study</ipd_time_frame>
    <ipd_access_criteria>Data access requests will be reviewed by the internal committee of Brest University Hospital. Requestors will be required to sign and complete a data access agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

